Back
Pliant Therapeutics Stock Price Chart
Sponsored
PLRX
Sponsored
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Sell
19
PLRX
Pliant Therapeutics
Last Price:
11.81
Seasonality Move:
40.29%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Pliant Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.46 | Sell |
20-day SMA: | 13.68 | Sell |
50-day SMA: | 14.85 | Sell |
200-day SMA: | 16.03 | Sell |
8-day EMA: | 12.54 | Sell |
20-day EMA: | 13.39 | Sell |
50-day EMA: | 14.51 | Sell |
200-day EMA: | 16.57 | Sell |
Pliant Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.82 | Sell |
Relative Strength Index (14 RSI): | 28.07 | Sell |
Chaikin Money Flow: | 572527 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.82 - 14.9) | Sell |
Bollinger Bands (100): | (14.18 - 17.6) | Sell |
Pliant Therapeutics Technical Analysis
Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 11.88 while PLRX 8-day simple moving average is 12.46, which is a Sell signal.
- The stock price of PLRX is 11.88 while Pliant Therapeutics 20-day SMA is 13.68, which makes it a Sell.
- Pliant Therapeutics 50-day simple moving average is 14.85 while PLRX share price is 11.88, making it a Sell technically.
- PLRX stock price is 11.88 and Pliant Therapeutics 200-day simple moving average is 16.03, creating a Sell signal.
PLRX Technical Analysis vs Fundamental Analysis
Sell
19
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a Sell
The current Pliant Therapeutics [PLRX] share price is $11.88. The Score for PLRX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
715.64M
Price in USD:
11.88
Share Volume:
607.76K
Pliant Therapeutics 52-Week Range
52-Week High:
28.80
52-Week Low:
11.21
Sell
19
Pliant Therapeutics (PLRX)
is a Sell
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?
The Pliant Therapeutics stock price is 11.88 USD today. -
Will PLRX stock go up or go down?
Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Pliant Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is overvalued.
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 11.88 while PLRX 8-day exponential moving average is 12.54, which is a Sell signal.
- The stock price of PLRX is 11.88 while Pliant Therapeutics 20-day EMA is 13.39, which makes it a Sell.
- Pliant Therapeutics 50-day exponential moving average is 14.51 while PLRX share price is 11.88, making it a Sell technically.
- PLRX stock price is 11.88 and Pliant Therapeutics 200-day simple moving average is 16.57, creating a Sell signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.25 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
- PLRX Moving Average Covergence Divergence (MACD) indicator is -0.82, suggesting Pliant Therapeutics is a Sell
- Pliant Therapeutics Relative Strength Index (RSI) is 28.07, which suggest Pliant Therapeutics is oversold
- The Bollinger Bands (25) for Pliant Therapeutics is (12.82 - 14.9), which suggest Pliant Therapeutics is a Sell
- The Bollinger Bands (100) for Pliant Therapeutics is (14.18 - 17.6), which suggest Pliant Therapeutics is a Sell
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.